Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 2633

Sort by

Sort Order Select

Journal Articles

DLBCL: who is high risk and how should treatment be optimized?

Anna Dabrowska-Iwanicka, Grzegorz S. Nowakowski

Blood (2024) 144 (25): 2573–2582.

https://doi.org/10.1182/blood.2023020779

Published: 2024

Journal Articles

Impact of soluble BCMA and non–T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma

Holly Lee, Michael Durante, Sheri Skerget, Deeksha Vishwamitra, Sacha Benaoudia, Sungwoo Ahn, Mansour Poorebrahim, Elie Barakat, David Jung, Noémie Leblay, Bachisio Ziccheddu, Benjamin Diamond, Marios Papadimitriou, Adam D. Cohen, Ola Landgren, Paola Neri, Francesco Maura, Nizar J. Bahlis

Blood (2024) 144 (25): 2637–2651.

https://doi.org/10.1182/blood.2024026212

Published: 2024

Includes: Supplemental data

Journal Articles

Introduction to a review series on high-risk aggressive lymphoma

Laurie H. Sehn, Michael Hallek

Blood (2024) 144 (25): 2561–2562.

https://doi.org/10.1182/blood.2023020913

Published: 2024

Journal Articles

Prominent expansion of EBV + large B cells obscuring follicular helper T-cell lymphoma

Leonard N. Yenwongfai, Ivo M. B. Francischetti

Blood (2024) 144 (25): 2682.

https://doi.org/10.1182/blood.2024026909

Published: 2024

Journal Articles

Peripheral T-cell lymphoma: are all patients high risk?

Lauren Shea, Neha Mehta-Shah

Blood (2024) 144 (25): 2604–2612.

https://doi.org/10.1182/blood.2023020912

Published: 2024

Journal Articles

Primary large B-cell lymphomas of immune-privileged sites

Mark Roschewski, James D. Phelan, Elaine S. Jaffe

Blood (2024) 144 (25): 2593–2603.

https://doi.org/10.1182/blood.2023020911

Published: 2024

Journal Articles

The high-grade B-cell lymphomas: double hit and more

Andrew J. Davies

Blood (2024) 144 (25): 2583–2592.

https://doi.org/10.1182/blood.2023020780

Published: 2024

Journal Articles

Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study

Blood blood.2024025624.

https://doi.org/10.1182/blood.2024025624

Published: 2024

Includes: Supplemental data

Journal Articles

Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

Rajshekhar Chakraborty, Saurabh Zanwar, Ute Hegenbart, Divaya Bhutani, Morie A. Gertz, Angela Dispenzieri, Shaji Kumar, Anita D’Souza, Anannya Patwari, Andrew Cowan, GuiZhen Chen, Paolo Milani, Giovanni Palladini, Vaishali Sanchorawala, Geethika Bodanapu, Stefan O. Schönland, Suzanne Lentzsch, Eli Muchtar

Blood (2024) 144 (25): 2613–2624.

https://doi.org/10.1182/blood.2024025899

Published: 2024

Includes: Supplemental data

Journal Articles

Deuterated water labeling in ibrutinib-treated patients with CLL: leukemia cell kinetics correlate with IGHV , ZAP-70, and MRD

Ekaterina Kim, Shih-Shih Chen, Mariela Sivina, Hyunsoo Hwang, Xuelin Huang, Alessandra Ferrajoli, Nitin Jain, William G. Wierda, Dominik Wodarz, Nicholas Chiorazzi, Jan A. Burger

Blood (2024) 144 (25): 2678–2681.

https://doi.org/10.1182/blood.2024025683

Published: 2024

Includes: Supplemental data

Journal Articles

Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesis

Blood blood.2024025690.

https://doi.org/10.1182/blood.2024025690

Published: 2024

Includes: Supplemental data

Journal Articles

DLBclass: A Probabilistic Molecular Classifier to Guide Clinical Investigation and Practice in DLBCL

Björn Chapuy, Timothy R. Wood, Chip Stewart, Andrew J. Dunford, Kirsty Wienand, Sumbul J. Khan, Nazli Serin, Meng Wang, Eleonora Calabretta, Joji Shimono, Samantha Van Seters, Sam Wiseman, Saveliy Belkin, David Isaac Heiman, Robert A Redd, Margaret A. Shipp, Gad Getz

Blood blood.2024025652.

https://doi.org/10.1182/blood.2024025652

Published: 2024

Includes: Supplemental data

Journal Articles

Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphoma

Blood (2024) 144 (24): 2490–2502.

https://doi.org/10.1182/blood.2024024381

Published: 2024

Includes: Supplemental data

Journal Articles

Follicular lymphoma comprises germinal center–like and memory-like molecular subtypes with prognostic significance

Camille Laurent, Preeti Trisal, Bruno Tesson, Sahil Seth, Alicia Beyou, Sandrine Roulland, Bastien Lesne, Nathalie Van Acker, Juan-Pablo Cerapio, Loïc Chartier, Arnaud Guille, Matthew E. Stokes, C. Chris Huang, Sarah Huet, Anita K. Gandhi, Franck Morschhauser, Luc Xerri

Blood (2024) 144 (24): 2503–2516.

https://doi.org/10.1182/blood.2024024496

Published: 2024

Includes: Supplemental data

Journal Articles

T-cell lymphomas in recipients of CAR-T cells: assessing risks and causalities

Jingqiong Hu, Cynthia E. Dunbar

Blood (2024) 144 (24): 2473–2481.

https://doi.org/10.1182/blood.2024025828

Published: 2024

Journal Articles

ADAR1-regulated cytoplasmic dsRNA-sensing pathway is a novel mechanism of lenalidomide resistance in multiple myeloma

Mun Yee Koh, Tae-Hoon Chung, Nicole Xin Ning Tang, Sabrina Hui Min Toh, Jianbiao Zhou, Tze King Tan, Leilei Chen, Wee Joo Chng, Phaik Ju Teoh

Blood blood.2024024429.

https://doi.org/10.1182/blood.2024024429

Published: 2024

Includes: Supplemental data

Journal Articles

Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis

Seung Kwon Koh, Hyojin Kim, Bohwa Han, Hantae Jo, Junsang Doh, Jeehun Park, Prof, Minh Ha Nguyen, Hyun-Young Kim, Haneul Kim, Seung-Hwan Lee, Chan Hyuk Kim, Duck Cho

Blood blood.2024025673.

https://doi.org/10.1182/blood.2024025673

Published: 2024

Includes: Supplemental data

Journal Articles

The GATA-3-dependent transcriptome and tumor microenvironment are regulated by eIF4E and XPO1 in T-cell lymphomas

Nermin Kady, Suhaib Abdelrahman, Ahmar Rauf, Alyssa Burgess, Jonathan Weiss, Hirushi Gunasekara, Neal Thomas Ramseier, Ira P Maine, Alejandro Zevallos-Morales, Vanessa Perez-Silos, Ashley Wolfe, Alexandra Hristov, Noah A Brown, Kedar V Inamdar, Maria Sverdlov, Ying Samuel Hu, Carlos Murga-Zamalloa, Chenguang Wang, Ryan A Wilcox

Blood blood.2024025484.

https://doi.org/10.1182/blood.2024025484

Published: 2024

Includes: Multimedia, Supplemental data

Journal Articles

Efficacy and Safety of Daratumumab in Intermediate/High-risk Smoldering Multiple Myeloma: Final Analysis of CENTAURUS

Blood blood.2024025897.

https://doi.org/10.1182/blood.2024025897

Published: 2024

Includes: Supplemental data

Journal Articles

Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies

Blood (2024) 144 (23): 2375–2388.

https://doi.org/10.1182/blood.2023023616

Published: 2024

Includes: Supplemental data

NARROW

DLBCL: who is high risk and how should treatment be optimized?

Impact of soluble BCMA and non–T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma

Introduction to a review series on high-risk aggressive lymphoma

Prominent expansion of EBV + large B cells obscuring follicular helper T-cell lymphoma

Peripheral T-cell lymphoma: are all patients high risk?

Primary large B-cell lymphomas of immune-privileged sites

The high-grade B-cell lymphomas: double hit and more

Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study

Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

Deuterated water labeling in ibrutinib-treated patients with CLL: leukemia cell kinetics correlate with IGHV , ZAP-70, and MRD

Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesis

DLBclass: A Probabilistic Molecular Classifier to Guide Clinical Investigation and Practice in DLBCL

Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphoma

Follicular lymphoma comprises germinal center–like and memory-like molecular subtypes with prognostic significance

T-cell lymphomas in recipients of CAR-T cells: assessing risks and causalities

ADAR1-regulated cytoplasmic dsRNA-sensing pathway is a novel mechanism of lenalidomide resistance in multiple myeloma

Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis

The GATA-3-dependent transcriptome and tumor microenvironment are regulated by eIF4E and XPO1 in T-cell lymphomas

Efficacy and Safety of Daratumumab in Intermediate/High-risk Smoldering Multiple Myeloma: Final Analysis of CENTAURUS

Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only